Weaver Consulting Group
BMY icon

Weaver Consulting Group’s Bristol-Myers Squibb BMY Stock Holding History

Weaver Consulting Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$219K Buy
+3,502
New +$221K 0.04% 284
2025
Q1 		– Sell
-3,570
Closed -$202K – 225
2024
Q4 		$202K Buy
+3,570
New +$199K 0.06% 211
2024
Q2 		– Sell
-4,632
Closed -$251K – 206
2024
Q1 		$251K Buy
4,632
+200
+5% +$10.2K 0.09% 169
2023
Q4 		$227K Sell
4,432
-148
-3% -$7.77K 0.09% 177
2023
Q3 		$266K Sell
4,580
-125
-3% -$7.66K 0.12% 146
2023
Q2 		$301K Sell
4,705
-7
-0.1% -$469 0.13% 137
2023
Q1 		$327K Sell
4,712
-227
-5% -$16K 0.15% 127
2022
Q4 		$355K Sell
4,939
-635
-11% -$47.9K 0.18% 110
2022
Q3 		$396K Sell
5,574
-3
-0.1% -$218 0.23% 90
2022
Q2 		$429K Sell
5,577
-480
-8% -$36.6K 0.24% 83
2022
Q1 		$442K Hold
6,057
– – 0.21% 86
2021
Q4 		$378K Sell
6,057
-347
-5% -$20.4K 0.18% 104
2021
Q3 		$379K Buy
6,404
+264
+4% +$17.4K 0.21% 98
2021
Q2 		$410K Buy
6,140
+800
+15% +$52.2K 0.23% 90
2021
Q1 		$337K Sell
5,340
-201
-4% -$12.5K 0.21% 92
2020
Q4 		$344K Sell
5,541
-188
-3% -$11.6K 0.21% 89
2020
Q3 		$345K Sell
5,729
-279
-5% -$16.8K 0.2% 77
2020
Q2 		$353K Hold
6,008
– – 0.21% 75
2020
Q1 		$335K Buy
6,008
+102
+2% +$6.23K 0.22% 69
2019
Q4 		$300K Hold
5,906
– – 0.16% 83
2019
Q3 		$263K Buy
5,906
+200
+4% +$9.4K 0.14% 87
2019
Q2 		$259K Hold
5,706
– – 0.14% 84
2019
Q1 		$263K Buy
+5,706
New +$284K 0.07% 182

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Weaver Consulting Group's BMY Position: Q3 2026 in Review

Weaver Consulting Group opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,502 shares worth $219K. The stake represents 0.04% of the portfolio and ranks #284 among its holdings. This is a return to the name: Weaver Consulting Group previously reported a position in BMY as recently as Q4 2024.

Weaver Consulting Group first reported a position in BMY in Q1 2019 and has held it in 23 quarters since. The position peaked at $442K in Q1 2022. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Weaver Consulting Group held 3,502 shares of Bristol-Myers Squibb worth $219K as of Q3 2026.
  • Bristol-Myers Squibb was a new Weaver Consulting Group position in Q3 2026.
  • Bristol-Myers Squibb made up 0.04% of Weaver Consulting Group's portfolio in Q3 2026, its #284 holding.
  • Weaver Consulting Group first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 23 quarters since.
  • Weaver Consulting Group's Bristol-Myers Squibb position peaked at $442K in Q1 2022.
  • 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Weaver Consulting Group's 13F filing for Q3 2026, filed 7 Oct 2026.